VC  Sante Ventures

https://sante.com/





     Office Locations:

4203 Montrose Blvd., Suite 250
Houston, TX 77006
Phone: 512-721-1200

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 2006, Sante Ventures invests primarily in seed and early-stage companies developing innovative new medical technologies and healthcare services. The firm has $260 million under management across two funds. Sante Ventures invests nationally with a focus on the Central U.S., and has offices in Austin, Houston and Boston. The firm maintains a close working relationship with Austin Ventures. Sante generally invests $2-6 million per round and targets $4-12 million in total capital invested over the life of a company, but is flexible based on the needs of the company.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Billy Cohn MD Venture Partner
    Brett Skukauski CPA Controller
    Brooke Jones Head of Capital Formation
    Casey Cunningham MD Chief Scientific Officer
    David Kaufman Chief Operating Office

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      02/16/2021


      Iterion Therapeutics


      TX


      $17,000,000


      Series B


      09/23/2020


      Libra Therapeutics


      CA


      $29,000,000


      Series A


      06/25/2020


      Cryosa


      MN


      $8,250,000


      Series A-2


     

    Portfolio companies include:

     

    Recent News: